国家食品药品监管局昨天发布2012年药品不良反应监测年度报告，全年共收到药品不良反应/事件报告120万余份，其中56.7%的不良反应是因患者使用的注射剂；24万份严重药品不良反应报告中，注射剂更是占到77.6%。此外，上述药品不良反应事件中，过半的给药途径，都是静脉注射。

State food and drug supervision bureau of adverse drug reactions monitoring in 2012 annual report released yesterday,Received report adverse drug reactions/events throughout the year more than 1.2 million copies,56.7% of adverse reactions for patients with injection;240000 serious adverse drug reactions report,Injection is also accounted for 77.6%.In addition,The adverse drug reactions,More than half of the delivery way,Are intravenous injection.

　　报告显示，医疗机构依然是药品不良反应报告的主体，占报告的74.8%，药品生产经营企业的报告比例有提高。

According to the report,Medical institutions is still the adverse drug reactions the body of the report,Accounting for 74.8% of the report,A proportion of the reports of pharmaceutical production and operation enterprises.

　　“静脉注射给药一直是临床用药的较高风险因素”，国家药监局药品安全监管司司长闫敏介绍，静脉注射主要用于急症、重症和不能口服给药病人的救治和治疗。但在实际临床中，使用静脉注射药品存在误区，部分消费者主动要求医生给予输液治疗，认为输液比吃药更有效。2012年，全国药品不良反应监测网络收到的过敏性休克导致患者死亡病例中，85%以上为静脉给药。因此，减少不合理使用注射剂带来的不良反应发生风险，一方面是医疗机构应加强对注射剂使用的监管，另一方面患者也应消除认识上的误区，改变对注射剂的心理依赖。

"Intravenous drug delivery has always been a high risk factor of clinical application",State food and drug safety supervision department 闫敏 is introduced,Intravenous injection is mainly used for emergency/Intensive and oral medicine to the patient's treatment and treatment.But in the actual clinical,Intravenous drug use existence erroneous zone,Some consumers asked the doctor to give the transfusion treatment actively,Think infusion is more effective than pills.In 2012,,The national adverse drug reaction monitoring network received anaphylactic shock cause patient death cases,More than 85% for intravenous administration.so,Reduce the bad reaction caused by unreasonable use of injection risk,On the one hand, medical institutions should strengthen the supervision over the use of injection,On the other hand, patients should also eliminate the misconceptions in understanding,Change the psychological dependence on injection.

　　闫敏说，口服给药一旦达到治疗必须的血药浓度后，即可达到与静脉给药相同的治疗效果。同时，不良反应发生风险较静脉给药低。（记者魏铭言）

闫敏 said,Oral medicine once treatment must be reached after the blood drug concentration,Can achieve the same as the intravenous administration of therapeutic effect.At the same time,Risk of adverse reactions was lower than those of intravenous medication.(Reporter wei MingYan)